Inflammatory arthritis in pediatric patients with morphea

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Morphea or localized scleroderma is an inflammatory disorder resulting in fibrosis of the skin and subcutaneous tissues. Joint contractures, arthralgias, and functional compromise are recognized associations of pediatric morphea. The co-existence of inflammatory arthritis and morphea is not well-described in the literature. Objective: To investigate the relationship between pediatric morphea and inflammatory arthritis with regards to cutaneous, musculoskeletal, and laboratory findings and treatment regimens. Methods: A systematic retrospective chart review of 53 patients with pediatric morphea was performed and analyzed for morphea subtypes, arthritic joint involvement, serum autoantibodies, and therapeutic interventions. Results: Eleven out of 53 patients had polyarthritis that involved joints unrelated to the site of the cutaneous morphea. These patients were mostly girls with either the linear or generalized subtypes of morphea. Serum levels of antinuclear antibodies were more significantly elevated in patients with arthritis. All children were treated with methotrexate in addition to other systemic or topical immunosuppressive agents. Limitations: This was a small, single-center retrospective study. Conclusion: Pediatric morphea co-existed with inflammatory arthritis in 11 of 53 children. Further understanding and appreciation of this relationship may direct more intensive therapy and musculoskeletal screening.

Original languageEnglish (US)
Pages (from-to)47-51.e2
JournalJournal of the American Academy of Dermatology
Volume79
Issue number1
DOIs
StatePublished - Jul 1 2018

Fingerprint

Localized Scleroderma
Arthritis
Pediatrics
Joints
Skin
Antinuclear Antibodies
Subcutaneous Tissue
Arthralgia
Contracture
Immunosuppressive Agents
Serum
Methotrexate
Autoantibodies
Fibrosis
Therapeutics
Retrospective Studies

Keywords

  • connective tissue disease
  • localized scleroderma
  • morphea
  • pediatric dermatology
  • rheumatology

PubMed: MeSH publication types

  • Journal Article

Cite this

@article{f0b58a70645947dea61082d7c08619d9,
title = "Inflammatory arthritis in pediatric patients with morphea",
abstract = "Background: Morphea or localized scleroderma is an inflammatory disorder resulting in fibrosis of the skin and subcutaneous tissues. Joint contractures, arthralgias, and functional compromise are recognized associations of pediatric morphea. The co-existence of inflammatory arthritis and morphea is not well-described in the literature. Objective: To investigate the relationship between pediatric morphea and inflammatory arthritis with regards to cutaneous, musculoskeletal, and laboratory findings and treatment regimens. Methods: A systematic retrospective chart review of 53 patients with pediatric morphea was performed and analyzed for morphea subtypes, arthritic joint involvement, serum autoantibodies, and therapeutic interventions. Results: Eleven out of 53 patients had polyarthritis that involved joints unrelated to the site of the cutaneous morphea. These patients were mostly girls with either the linear or generalized subtypes of morphea. Serum levels of antinuclear antibodies were more significantly elevated in patients with arthritis. All children were treated with methotrexate in addition to other systemic or topical immunosuppressive agents. Limitations: This was a small, single-center retrospective study. Conclusion: Pediatric morphea co-existed with inflammatory arthritis in 11 of 53 children. Further understanding and appreciation of this relationship may direct more intensive therapy and musculoskeletal screening.",
keywords = "connective tissue disease, localized scleroderma, morphea, pediatric dermatology, rheumatology",
author = "Kashem, {Sakeen W.} and Correll, {Colleen K} and Vehe, {Richard K} and Hobday, {Patricia M} and Binstadt, {Bryce A} and Sheilagh Maguiness",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.jaad.2018.03.005",
language = "English (US)",
volume = "79",
pages = "47--51.e2",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Inflammatory arthritis in pediatric patients with morphea

AU - Kashem, Sakeen W.

AU - Correll, Colleen K

AU - Vehe, Richard K

AU - Hobday, Patricia M

AU - Binstadt, Bryce A

AU - Maguiness, Sheilagh

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background: Morphea or localized scleroderma is an inflammatory disorder resulting in fibrosis of the skin and subcutaneous tissues. Joint contractures, arthralgias, and functional compromise are recognized associations of pediatric morphea. The co-existence of inflammatory arthritis and morphea is not well-described in the literature. Objective: To investigate the relationship between pediatric morphea and inflammatory arthritis with regards to cutaneous, musculoskeletal, and laboratory findings and treatment regimens. Methods: A systematic retrospective chart review of 53 patients with pediatric morphea was performed and analyzed for morphea subtypes, arthritic joint involvement, serum autoantibodies, and therapeutic interventions. Results: Eleven out of 53 patients had polyarthritis that involved joints unrelated to the site of the cutaneous morphea. These patients were mostly girls with either the linear or generalized subtypes of morphea. Serum levels of antinuclear antibodies were more significantly elevated in patients with arthritis. All children were treated with methotrexate in addition to other systemic or topical immunosuppressive agents. Limitations: This was a small, single-center retrospective study. Conclusion: Pediatric morphea co-existed with inflammatory arthritis in 11 of 53 children. Further understanding and appreciation of this relationship may direct more intensive therapy and musculoskeletal screening.

AB - Background: Morphea or localized scleroderma is an inflammatory disorder resulting in fibrosis of the skin and subcutaneous tissues. Joint contractures, arthralgias, and functional compromise are recognized associations of pediatric morphea. The co-existence of inflammatory arthritis and morphea is not well-described in the literature. Objective: To investigate the relationship between pediatric morphea and inflammatory arthritis with regards to cutaneous, musculoskeletal, and laboratory findings and treatment regimens. Methods: A systematic retrospective chart review of 53 patients with pediatric morphea was performed and analyzed for morphea subtypes, arthritic joint involvement, serum autoantibodies, and therapeutic interventions. Results: Eleven out of 53 patients had polyarthritis that involved joints unrelated to the site of the cutaneous morphea. These patients were mostly girls with either the linear or generalized subtypes of morphea. Serum levels of antinuclear antibodies were more significantly elevated in patients with arthritis. All children were treated with methotrexate in addition to other systemic or topical immunosuppressive agents. Limitations: This was a small, single-center retrospective study. Conclusion: Pediatric morphea co-existed with inflammatory arthritis in 11 of 53 children. Further understanding and appreciation of this relationship may direct more intensive therapy and musculoskeletal screening.

KW - connective tissue disease

KW - localized scleroderma

KW - morphea

KW - pediatric dermatology

KW - rheumatology

UR - http://www.scopus.com/inward/record.url?scp=85046805588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046805588&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2018.03.005

DO - 10.1016/j.jaad.2018.03.005

M3 - Article

VL - 79

SP - 47-51.e2

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 1

ER -